PPARGC1A and diabetes mellitus: PKM2-specific activation with TEPP-46 reduced toxic metabolites induced by hyperglycemia and restored the altered mitochondrial metabolism partially by improving glycolytic flux and preserving PGC-1α activity in mice with diabetes.